Check out the #OpenAccess paper at the following link:
link.springer.com/article/10.1...
Thanks for reading!

Some good news: Prolactin sensitizes HT29 cells to TRAIL-mediated apoptosis. We tested the efficacy of our next generation dual affinity liposomes, based on immune cell delivery! #nanomedicine

We built a computational model of the JAK2/STAT3 signaling pathway in response to late-pregnancy PRL levels!
Freely available at:
doi.org/10.5281/zeno...

Cancer stem-associated markers and EMT increase with prolactin treatments.

On the ATCC website, there are a total of 52 human colorectal cell lines available for cancer research applications. Only six are derived from female patients, highlighting that there is a disproportionate focus on male disease even at the level of research material availability.

We found that pregnancy prolactin levels cause biphasic STAT3 phosphorylation and increased JAG1 and NICD expression.

Pregnant colorectal cancer patients have larger tumors yet fewer options exist for anticancer interventions compared to non-pregnant colorectal cancer patients.

Before we get into the science, this was my first opportunity to publish a second, “native language” abstract with the paper… so we were able to include a Spanish language version in lead author @MariaLCavestany ‘s mother tongue, muy bien! 🇪🇸

Yesterday, Drs. Beraud and Marvin and Sarah organized a networking event during the @amsocmatbio.bsky.social Meeting in Baltimore.

We were delighted to connect with nearly 20 AIMBE Fellows, Emerging Leaders, and Council Representatives over an evening of food and conversation 🍤

(2/4)